No summary has been written for this.
Tema Oncology ETF is an actively managed exchange-traded fund focused on companies involved in cancer treatment and oncology care. Tema Oncology ETF seeks to invest primarily in publicly listed businesses that derive a substantial share of their revenue from oncology, giving the portfolio a concentrated exposure to drug developers, biotechnology firms, and large pharmaceutical companies with meaningful cancer-related programs. Its holdings can include companies working across targeted therapies, immuno-oncology, diagnostics, and supportive care, reflecting the broader ecosystem of cancer research and treatment. The fund is designed to offer investors access to a specialized segment of the health care market centered on one of the most important therapeutic areas in medicine. By combining U.S. and international issuers, Tema Oncology ETF serves as a thematic vehicle for gaining diversified exposure to the global oncology industry.
The latest articles about CANC.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about CANC also mention these. Each card shows that asset’s own numbers for the past 24 hours.